Randomized Clinical Trial
Copyright ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Dec 6, 2020; 8(23): 5999-6008
Published online Dec 6, 2020. doi: 10.12998/wjcc.v8.i23.5999
Efficacy and economic benefits of a modified Valsalva maneuver in patients with paroxysmal supraventricular tachycardia
Wei Wang, Teng-Fei Jiang, Wei-Zhong Han, Lin Jin, Xiao-Jing Zhao, Ying Guo
Wei Wang, Wei-Zhong Han, Lin Jin, Xiao-Jing Zhao, Internal Medicine-Cardiovascular Department, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China
Teng-Fei Jiang, Department of Nursing, The First Affiliated Hospital of Shandong First Medical University
Ying Guo, Department of Nursing, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China
Author contributions: Guo Y designed the study; Wang W, Jin L, Jiang TF, and Zhao XJ conducted the research; Han WZ and Wang W analyzed the data and wrote the first draft of the manuscript; Han WZ and Guo Y revised the paper; and all authors contributed to writing or critically reviewing the manuscript.
Supported by Key Research and Development Project of Shandong Province, No. 2016GST201224; and Jinan Clinical Medicine Science and Technology Innovation Plan, No. 201907056.
Institutional review board statement: The study protocol was approved by the ethics committee of Shandong Provincial Hospital Affiliated to Shandong University.
Clinical trial registration statement: This study is registered at Shandong Provincial Hospital Affiliated to Shandong First Medical University. The registration identification number is 2019-084.
Informed consent statement: All study participants or their legal guardian provided informed written consent regarding personal and medical data collection prior to study enrolment.
Conflict-of-interest statement: All authors declare no conflict of interest.
Data sharing statement: The datasets used or analyzed during the current study are available from the corresponding author on reasonable request.
CONSORT 2010 statement: The authors have read the CONSORT 2010 Statement, and the manuscript was prepared and revised according to the CONSORT 2010 Statement.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ying Guo, MSN, RN, Chief Nurse, Department of Nursing, Shandong Provincial Hospital Affiliated to Shandong First Medical University, No. 324 Jingwu Road, Jinan 250021, Shandong Province, China. guoyingslyy@163.com
Received: June 28, 2020
Peer-review started: June 28, 2020
First decision: July 24, 2020
Revised: July 30, 2020
Accepted: October 12, 2020
Article in press: October 12, 2020
Published online: December 6, 2020
Processing time: 159 Days and 0.6 Hours
ARTICLE HIGHLIGHTS
Research background

Previous studies in western countries suggested that a modified Valsalva maneuver (VM) may improve the success rate of paroxysmal supraventricular tachycardia (PSVT) conversion. However, the relative efficacy and economic benefits of a modified VM as compared with the standard VM in Chinese patients with PSVT have not been evaluated.

Research motivation

The relative efficacy and economic benefits of a modified VM as compared with the standard VM in Chinese patients with PSVT have not been evaluated; therefore, we aimed to compare the clinical efficacy and economic efficiency, as well as the safety of a modified VM vs standard VM in Chinese patients with PSVT.

Research objectives

In this study, we aimed to compare the clinical efficacy and economic efficiency, as well as the safety of a modified VM vs standard VM in Chinese patients with PSVT.

Research methods

This study included adult patients (aged older than 18 years) with electrocardiography (ECG)-confirmed PSVT who were admitted to the Cardiology Department of Shandong Provincial Hospital between October 2017 and September 2019. All patients were randomized into the modified VM group or standard VM group using opaque-sealed envelopes. Written informed consent was obtained from all participants. Conversion via VM was performed up to three times. The 12-lead ECG or ECG monitoring was used to determine the cardioversion. In both groups, the procedure for standard VM or modified VM was repeated up to 3 times in unresponsive patients. Basic demographics, past history and vital signs of patients in both groups were recorded. The success rates of cardioversion after one or multiple sessions of VM in the two patients groups were recorded. The recovery of sinus rhythm confirmed by ECG was defined as successful cardioversion. Potential adverse events during the performance of the modified or standard VM were observed.

Research results

Overall, 361 patients were enrolled, 180 in the modified VM group and 181 in the standard VM group. No significant differences were observed between the two groups in terms of the proportion of males, age, weight, systolic blood pressure, diastolic blood pressure, heart rate, serum potassium at admission, previous onset of PSVT, history of hypertension, coronary heart disease, and prevalence of pneumonia. The success rates of sinus rhythm restoration after a single session or multiple sessions of VM were both higher in patients allocated to the modified VM group than in those allocated to the standard VM group (χ2 values were 33.724 and 22.008, both P < 0.001, respectively). The incidence of adverse events did not differ significantly between the two groups during treatment. Non-serious adverse events occurred in patients in both groups, and the incidences were comparable between the groups. These adverse events resolved spontaneously without any treatment. The average cost of the clinical visit for patients in the modified VM group was RMB 113.32 ± 45.22, whereas that for patients in the standard VM group was RMB 140.91 ± 37.08, which showed that the modified VM is cost-effective compared with standard VM (P < 0.05). According to the scores on the scale of acceptance, acceptance among patients in the modified VM group did not differ statistically from that of patients in the standard VM group (3.67 ± 0.69 vs 3.54 ± 0.66, Kruskal-Wallis test, χ2 = 1.855, P = 0.064).

Research conclusions

In summary, the modified VM can effectively improve the success rate of cardioversion in patients with PSVT. The modified VM is effective and involves less cost than standard VM, and the safety and acceptance of the treatments among the PSVT patients were comparable. Termination of PSVT via the modified VM can be managed by primary healthcare professionals and patients themselves.

Research perspectives

This study focused on the effect of physical manipulation on supraventricular tachycardia. The intervention scheme was designed by random control, and the effect was evaluated by various evaluation indices. It has important guiding significance for clinical work. The maneuver is simple and easy to operate, has good safety, a low incidence of adverse reactions, can reduce personal and medical insurance expenses, has good economic benefits, and can be popularized in community hospitals and other primary hospitals.